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Clinical Assessment of Auditory
Dysfunction
by W. G. Thomas*
Many drugs, chemicals substances and agents are potentially toxic to the human auditory
system. The extent oftoxicity depends on numerous factors. With few exceptions, toxicity in the
auditory system affects various organs or cells within the cochlea or vestibular system, with
brain stem and other central nervous system involvement reported with some chemicals and
agents. This ototoxicity usually presents as a decrease in auditory sensitivity, tinnitus and/or
vertigo or loss of balance. Classical and newer audiological techniques used in clinical
assessment are beneficial in specifying the site of lesion in the cochlea, although auditory test
results, themselves, give little information regarding possible pathology or etiology within the
cochlea. Typically, ototoxicity results in high frequency hearing loss, progressive as afunction of
frequency, usually accompanied by tinnitus and occasionally by vertigo or loss of balance.
Auditory testing protocols are necessary to document this loss in auditory function.
Introduction
Clinical assessment of auditory dysfunction is a
broad topic, potentially covering many different
methods ofassessment and many types ofauditory
dysfunction. It is well known that auditory dys-
function can be caused by literally hundreds of
different problems or pathologies. Auditory dys-
function can occur as a result of peripheral or
central pathologies, or it can occur as a local
manifestation of some systemic disease. Auditory
dysfunction can be caused by extrinsic factors
(infections, drugs, trauma, tumors, neurologic dis-
eases, metabolic diseases) orintrinsic factors (genet-
ic, etc.). Auditory dysfunction may be congenital or
acquired. If congenital, it may be genetic, with
hearing loss occurring alone as in the case of
Mondini'saplasia, occurringintheform ofasyndrome
with otherabnormalities such as Usher's syndrome,
or may occur as a chromosomal abnormality. It may
also be congenital but nongenetic, with hearing loss
occurring alone in the case of many ototoxic agents,
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or, occurring with a host of other abnormalities as
in the case of maternal rubella, anoxia, bacterial
infections and metabolic disorders. As indicated,
auditory dysfunction may also be acquired, either
genetic or nongenetic. Ifgenetic, hearing loss may
occur alone as in the case of familial progressive
sensorineural deafness or in conjunction with other
abnormalities as in the case of Alport's syndrome.
Ifnongenetic, hearing loss may occur as a result of
numerous pathologies, including inflammatory dis-
eases, ototoxicity, neoplastic disorders, traumatic
injury, metabolic disorders, vascular insufficiency,
or central nervous system diseases such as multiple
sclerosis.
It should be obvious from this short description
that the exact cause of a specific auditory dysfunc-
tion is frequently impossible to determine. It is also
of interest to note that toxic agents may cause
congenital or acquired auditory dysfunction. Since
this conference is concerned with target organ
toxicity-in the present case, specifically the audi-
tory system-the remainder ofthis paper will deal
especially with this topic. It should be remem-
bered, however, that the same clinical assessment
is appropriate to a wide range ofauditory dysfunc-
tions and not specific to those caused by ototoxicity.
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It is probably safe to say that the action of any
substance on an organ orcell can be eitherbeneficial
or detrimental, depending on many factors. Some
controversy continues, however, as to whether any
chemical, drug or agent has a beneficial effect on
the inner ear. Recent literature would indicate that
nearly 200 substances have some documentation in
the medical literature ofototoxicity (1-3). Although
these cannot be described within the current space
constraints, they can be separated into general
categories. These include: chemicals (carbon mon-
oxide, alcohol, nicotine, arsenic, potassium bro-
mate, etc.); heavy metals (lead, tin, gold, mercury,
etc.); antibiotics; diuretics; analgesics and antipy-
retics (salicylates, quinine, etc.); antineoplastics
(bleomycin, nitrogen mustard, cis-platinum); and
miscellaneous drugs (pentobarbital, hexadine). The
literature on chemical or drug ototoxicity for anti-
biotics and diuretics isextensive. Theaminoglycosides
have received the majority of attention; however,
other antibiotics, such as vancomycin, erythromy-
cin, chloramphenicol, polymyxin B and ampicillin,
have also been indicated as potentially ototoxic.
Diuretics have also received substantial research as
potentially ototoxic. Specifically, furosemide and
ethacrynic acid have ototoxic properties, or at least
potentiate ototoxicity. However, other diuretics
such as mannitol and the mercurials may be ototox-
ics. Perhaps the greatest body of literature with
regard to ototoxic effects concerns exposure to
noise. Auditory dysfunction following noise expo-
sure has been documented for more than 100 years.
It is an understatement and oversimplification to
describe the action of any chemical, drug or other
agent as complex, with potential ototoxic effects
dependent on many variables. However, this is also
an accurate statement. The mechanisms ofaction of
ototoxic substances or agents may injure or embar-
rass the entire organ, specific cells within the
organ, components of specific cells, or inhibit indi-
vidual biochemical pathways. This action has been
related to overall dose; duration of exposure; blood
serum levels in the case of chemicals, drugs or
heavy metals; general health of the subject and
underlying disease; age of subject; prior exposure;
renal impairment; individual susceptibility; and, of
course, possible potentiation and synergistic effects
of combinations of chemicals, drugs and other
agents. All of these factors create a rather confus-
ing picture with regard to true ototoxic effects and
may explain, to some extent, apparent disagree-
ments within the literature.
Auditory dysfunctions resulting from ototoxic
agents usually present as tinnitus, hearing loss
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and/or vertigo. Cochlear damage is usually an
orderly progression of hair cell loss in the organ of
Corti beginning in the basal turn and progressing
toward the apex. There appears first to be a
consistent destruction ofthe innerrow ofouterhair
cells, progressing to the outer two rows, with
preservation of the inner hair cells until over-
whelmingtoxicityoccursandeventualtotaldestruc-
tion ofthe organ of Corti. Injury to other cochlear
structureshasbeendemonstrated, including: changes
in the stria vasularis, suprastrial portion of the
spiral ligament, pericapillary tissues of the spiral
prominence, outer sulcus cells, and Reissner's mem-
brane. In addition, vestibular damage may occur,
specifically in the Type I hair cells of the cristae
ampullaris and in the utricle (4, 5). Auditory
dysfunction resultingfrom ototoxic agents is almost
always sensorineural. In most cases, this loss is
bilateral and symmetric, although there are excep-
tionsreported inthe literature. Hearingloss caused
by chemical orheavy metal toxicity may show brain
stem or central pathology and is usually associated
with a variety of other neurologic manifestations.
Clinical Test Battery
Clinical assessment of auditory dysfunction fol-
lows an orderly progression oftests to identify the
site of disorder. While the shape of the auditory
function may give information regarding possible
pathology or etiology, auditory tests are designed
to give primary information as to site-of-lesion. For
example, auditorytestsmayindicatethattheprimary
source ofpathology is in the cochlea. These results,
however, give no indication as to type ofpathology
(i.e., hair cell damage, damage to stria vascularis,
rupture of Reissner's membrane, etc.), nor do they
give information regarding possible etiology, since
many factors, including ototoxicity, can cause dam-
age to the cochlea. As a point of major differentia-
tion, auditorytests are designed to separate periph-
eral and central auditory disorders. The major
point of demarcation between peripheral and cen-
tral disorders is the synapse at the cochlear nucle-
us, between the first- and second-order neurons.
With this definition, pathologies inthe external ear,
middle ear, inner ear, and auditory nerve would be
considered peripheral disorders and pathologies in
the brain stem and cortex would be considered
centraldisorders. Otherauditory tests aredesigned
tohelp differentiate site-of-lesion withinthe periph-
eral or central auditory system. As defined, audi-
tory dysfunction in the peripheral system might be
expected to show the following characteristics:
ipsilateral symptoms, usual loss of sensitivity, dis-
tortion present in cochlear and auditory nerve
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cochlear and auditory nerve disorders. Central
auditory dysfunction might be characterized by
contralateral symptoms, frequently normal sensi-
tivity, and dysfunction in ability to transmit com-
plex stimuli. Differences in characteristics ofperiph-
eral and central auditory dysfunctions have led to
development ofdifferent auditory test batteries. In
peripheral testing, pure tone stimuli can conve-
niently be used. Central testing, however, usually
requires more subtle changes in stimuli and the use
of complex stimuli (6).
The classical peripheral auditory test battery
contains tests to differentiate among conductive,
cochlear and retrocochlear hearing loss. In addi-
tion, tests are available to aid in differentiating
sites-of-lesion within these three major areas. A
complete description ofauditory tests may be found
in several standard audiology textbooks (6-8). A
typical test battery might include the following
tests.
Pure Tone Thresholds (Air Conduction
and Bone Conduction)
Pure tone air conduction testing is used to mea-
sure the sensitivity ofthe ear to different frequen-
cies, when compared to normal hearing. Air con-
duction testing uses the entire auditory system
[i.e., external ear, middle ear, inner ear, eighth
cranial nerve (N VIIlth), and central nervous sys-
tems]. Pure tone bone conduction testing is used to
measure the sensitivity of the ear to different fre-
quencies when the external ear and middle earhave
been by-passed and sound is transmitted directly to
the inner ear, although this is an oversimplification.
The difference between air and bone conduction
scores is the first evidence ofconductive or sensori-
neural hearing loss.
Speech Reception Threshold (SRT)
SRT involves measurement of the sensitivity of
eartospeechmaterial. Thespeechmaterialsgenerally
used are spondee words (i.e., two syllable words
with equal emphasis on each syllable, like baseball
or airplane). The speech reception threshold should
agree with the average pure tone air conduction
results at 500, 1000 and 2000 Hz.
Speech Discrimination (SD)
Speech discrimination measures the ability of a
subject to transmit and understand complex stimuli
(speech). Speech discrimination lists are presented
at a level above threshold so that they can be heard
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withoutdifficulty, usually40 dB SL, andthe patient's
ability to discriminate is measured. The speech
materials generally used are short, single syllable,
phonetically balanced words.
Alternate Binaural Loudness Balance
(ABLB)
ABLB measures the presence or absence ofloud-
ness recruitment by having the subject balance the
loudness of a standard tone in one ear with an
alternatingtone in the pathologic ear. The presence
ofloudness recruitment is measured by the growth
ofloudnessinthepathologicear. Onecontraindication
of this test is that it cannot be used in bilaterally
symmetrical hearing loss.
Short Increment Sensitivity Index
(SISI)
The SISI test measures the ability ofa subject to
detect a 1 dB change in intensity at a level 20 dB
above threshold. This test can be used at any
frequency in either ear, regardless ofthe asymme-
try ofthe hearing loss. A positive SISI score (i.e.,
above 60%) is an indication of cochlear pathology.
Several modifications have been made to the classic
SISI procedure (9).
Tone Decay (TD)
Tone decay measures the fatigue or adaptation of
the auditory system to a constant stimuli. Tone
decay is measured as the decay in decibels from
threshold over a one minute period. A positive tone
decay (i.e., greaterthan 25 dB) is an indication ofN
VIIIth disorder. Modifications to this original tech-
nique have been reported in the literature (10-12).
Bekesy Tracings
The Bekesy tracings indicate threshold sensitiv-
ity measured on an automatic audiometer when the
tones are pulsed and when they are continuous.
Theoretically, the pathologicauditorysystem should
show more adaptation to a continuous tone than to
a pulsed tone. Particular patterns of tracings have
been identified with cochlear pathology and with
retrocochlear pathology. The automatic Bekesy au-
diometer is essentially under the control of the
subject. The subject is instructed to press a button
when he hears a tone and release the button when
the tone disappears. In this way, the patient auto-
matically traces his threshold for pulsed and con-
tinuous tones. Thus, the audiometer can be used in
several different ways.
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cally sweeps through frequencies from 100 Hz to
10,000 Hz, with the subject controlling the intensi-
ty. Pulse tones are used first, then continuous tones
are plotted on the same audiogram, showing the
amount of adaptation between pulsed and continu-
ous tones (13).
Fixed Frequency. The audiometer can be set
foroneparticularfrequencyandthreshold forpulsed
and continuous tones are plotted as a function of
time. The purpose is to look at the amount of
adaptation occurring at one particular frequency
(13).
Backward Sweep. The audiometer can also be
swept from 10,000 Hz to 100 Hz, showing whether
the adaptation is a function of time or frequency
(14).
Most Comfortable Loudness. The subject is
instructed to keep the tone at his most comfortable
loudness, which makes this a suprathreshold test.
This modification is based on the concept that
abnormal adaptation first appears only athigh inten-
sities and eventually appears at lower levels, until
it finally appears at threshold. Abnormal decay ofa
continuous tone at suprathreshold levels is an indi-
cation of N VIIIth pathology (12).
Impedance
The study of impedance in the auditory system
involves an analysis of the acceptance or rejection
by this system of the flow of energy per unit of
time. In other words, how much is the flow of
energy impeded by this particular system? A sys-
tem with high impedance rejects or reflects the
majority ofenergy, while a system with low imped-
ance accepts or absorbs most of the energy and
reflects less. Normally, there are three components
which combine to determine the impedance of a
particular system: resistance, stiffness, and inertia
or mass. In order to accomplish this clinically, a
probe is placed in the external canal and sealed.
The probe emits a low frequency tone (220 Hz), and
a microphone in the probe measures the reflected
sound from the tympanic membrane. The amount of
sound reflected gives an indication of the integrity
of the external and middle ears. Normally, four
measures may be made-static compliance, tym-
panometry, acoustic reflex threshold and acoustic
reflex decay.
Static Compliance. Static compliance of the
middle ear is a measure ofmobility. Mass (inertia),
resistance (friction) and stiffness (or its reciprocal
compliance) work together in a complex manner to
facilitate, or impede, motion ofthe middle ear sys-
tem, as measured at the tympanic membrane (MT).
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Historically, static compliance has beentermed acous-
tic impedance or absolute impedance, although the
term compliance is a more descriptive term ofwhat
is actually measured. Static compliance denotes a
single number representing the mobility of the
middle ear system. Tympanometry is also a mea-
sure ofcompliance; however, this measure is made
overnumerous values as the MT moves in response
to changes in airpressure and, thus, is ameasure of
dynamic compliance.
Static compliance of the middle ear system is
measuredbyquantifyingthe sound energyreflected
from the MT. When the middle ear system is stiff,
more energy is reflected rather than absorbed or
transmitted through the middle ear. Therefore, a
stiff middle ear system is said to have low compli-
ance or high resistance. A flaccid middle ear mech-
anismabsorbs more energy and reflects less. There-
fore, this system has high compliance or low re-
sistance.
Static compliance can be measured in terms of
equivalent volume of air in cubic centimeters or in
acousticohms. Thistestrequirestwomeasurements:
one measurement made with the MT in a position of
low compliance by exerting an air pressure of +200
mm of water in the external ear relative to the
middle ear; the second measurement is made with
the MT in a position of maximum compliance (nor-
mally at 0 mm of water). Neither of these two
measures has any significance when taken alone.
However, by subtracting one measure from the
other, the external ear canal volume is effectively
cancelled, thus allowing a measurement value of
the middle ear mechanism. The compliance of the
normal middle ear system is influenced by many
variables, including age and sex. In general, how-
ever, normal staticcompliance valuesrangebetween
0.26 and 1.5 cc. A stiff middle ear system should
demonstrate a compliance value less than 0.26 cc,
while a flaccid middle ear system should have a
compliance greaterthan 1.5 cc. The normalrange of
absolute impedance in acoustic ohms is approxi-
mately 600 to 3000 ohms. Absolute values below
600 ohms indicate a very compliant ear, while val-
ues above 3000 ohms indicate a resistive middle ear
system.
Tympanometry. Tympanometry is the measure-
ment of eardrum compliance as the air pressure is
altered in the external ear relative to the middle
ear. These measurements are normallyrecorded on
agraph which represents acompliance-airpressure
function, called a tympanogram. A point of sig-
nificance is that the MT is at maximum compliance
when the air pressure in the middle ear is equal to
that in the external ear. Tympanometry can pro-
vide an indirect measure of existing middle ear
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external canal, where the eardrum shows its maxi-
mum compliance. Subjects who have intact MTs,
with no middle ear pathology and adequate eusta-
chian tube function, will showmaximum compliance
at atmospheric pressure or within + 50 mm of
atmospheric pressure. Subjects with intact MTs
and poor eustachian tube function will show maxi-
mum compliance at negative air pressure values.
Subjects with fluid in the middle ear will usually
never reach a point ofmaximum compliance, to the
maximum ofthe instrumentation, while those with
a resistive type middle ear pathology will show
very low compliance (high stiffness orresistance) at
atmospheric pressure.
AcousticReflex Threshold. The stapedial mus-
cle contracts reflexively when the ear is stimulated
with a sufficiently loud sound. In normal ears, the
acoustic reflex can be elicited with stimulation at
sensation levels of 70 to 95 dB. Contraction of the
middle ear muscles decreases the compliance ofthe
MT. This contraction occurs bilaterally. Inthe dem-
onstration ofthe acoustic reflex, the sudden change
in the relative compliance ofthe middle ear created
by the muscle contractions is utilized. Ifthe acous-
tic signal is sufficiently loud to elicit the bilateral
acoustic reflex, the resulting contraction of the
stapedius muscle in the probe ear will suddenly
decrease the compliance at the MT synchronously
withthepresentation ofthestimulus and thischange
in relative compliance can be observed as a sudden
deflection in the balance meter. The acoustic reflex
can be elicited by either contralateral stimulus pre-
sentation or ipsilateral stimulus presentation at
approximately the same stimulus levels. Also, the
reflex may be elicited with pure tone stimuli orwith
noise.
Reflex Decay. Reflex decay is a truly remark-
able phenomenon. In normal ears, contraction of
the middle ear muscles to an auditory stimulus of
1000 Hz or lower can be maintained for up to 45 sec
without obvious decay, fatigue or adaptation. In
subjects with retrocochlear lesions and somecochlear
lesions, the reflex appears normalwhen first turned
on. When the acoustic stimulus is sustained, how-
ever, reflex amplitude declines and may eventually
disappear. Klockoff and Anderson et al. (15, 16)
advocate the use of reflex decay as an indicator of
VIIIth nerve lesions. These authors have reported
a decay in the acoustic reflex for patients with
VIIIth nerve pathology when a stimulus is pre-
sented at areflex sensation level of10 dB for 10 sec.
When a stimulus is presented in this manner, the
amplitude of the reflex decays to a level of 50% or
less of the original amplitude in less than 10 sec-
onds. The same results have been found in normal
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ears at 4000 Hz, and to a lesser degree at 2000 Hz.
No decayis observed in normal ears at 500 and 1000
Hz, however.
PI-PB Function
The PI-PB (performance versus intensity forpho-
netically balanced words) function test, a special
use of speech discrimination, simply refers to the
discrimination test given at several different inten-
sities. In the case of cochlear pathology, the func-
tion should reach a plateau with increased intensity
and remain there, while in VIIlth nerve pathology,
the discrimination score becomes worse at high
intensities (17).
Central Auditory Dysfunction
Tests for central auditory dysfunction will not be
discussedinthispresentation. Thereaderisreferred
to several excellent texts describingthese tests (18,
19). The majority of tests used to identify central
auditorydysfunctionusecomplexstimulilikespeech
because changes in the central nervous system are
usually subtle. In general, the speech material is
changed in some way to reduce its redundancy and
increase its ability to detect subtle changes. Tests
have been designed which alter speech stimuli in
many ways. These include: submerging the speech
material in a background of noise; combining the
speech material with a competing message of dif-
ferent speech material, either in the contralateral
or ipsilateral ear; filtering the speech material to
reduce its intelligibility; interrupting the speech
material; accelerating the speech material; present-
ing different frequency bands ofspeech to different
ears; and, presenting two different speech mes-
sagessimultaneouslytothetwoears(dichoticspeech).
Some toxic substances effect the central nervous
system more than the peripheral system. These
includecarbon monoxide and heavymetals. Inthese
cases, complete clinical assessment would include
central auditory tests.
Brain Stem Tests
Several more recent auditory tests appear to
show promise in enhancing the clinical assessment
ofauditorydysfunction. The mostprominent appears
to be the auditory brain stem evoked response
(BSER, BER or ABR). This is one of several
evoked responses that have been identified in the
auditorysystem. Atpresent, thefollowingresponses
havebeenidentified: auditory nerveresponse (latency
1-4 msec); brain stem or fast responses (latency
2-12 msec); middle responses (latency 12-50 msec);
71sonomotorormuscleresponses (latency 10-50msec);
slow auditory responses (latency 50-300 msec); and
contingentnegative variation (CNV) (latency300-600
msec).
One of the more stable evoked potential mea-
sures is the brain stem response. This is a series of
vertex-positive waves followingaclickortone burst
with latencies from 1 to 10 msec (20-26). To date,
seven different waves have been identified and
associated with various nuclei in the auditory brain
stem system (21, 27). The most prominent and
visible wave of this series occurs with a latency of
approximately 6 msec and is called the V wave
(28-30). It is assumed to originate in the inferior
colliculus and is a good candidate for assessing the
higher auditory frequency responses occurring in
the basal turn of the cochlea. Other waves have
beenascribed totheauditorynerve (wave I), cochlear
nucleus (wave II), trapezoid body (wave III), lat-
eral limniscus (wave IV) and medial geniculate
(wave VI). The utility ofthe brain stem response as
aclinicaltoolseemstobeenhancedsincetheresponse
is extremely stable, is not unusually affected by
state of sleep, can be recorded from unconscious
patients, shows a maturational development, can
be recorded in a relatively short period oftime and
includes waves which are associated with various
nuclei in the auditory system ofthe brain stem (31,
32).
The latencies of the various waves of the brain
stem evoked response are extremely stable from
test to test in the same subject and between sub-
jects. In fact, the standard deviations around these
mean latencies range from 0.1 to 0.3 msec (33, 34).
In addition, the latency changes in a predictable
manner as the intensity ofthe stimulus is increased
or decreased. This latency versus intensity rela-
tionship makes the BSER a valuable tool in assess-
ing hearing function ofdifficult to test subjects. For
example, the mean latency ofthe V wave in normal
hearingsubjects at 70dB abovethresholdisapprox-
imately 5.5 msec. As intensity is decreased to 10 dB
above threshold, the latency increases to approxi-
mately 8.0 msec (35). Therefore, a measure of the
latency of the V wave in a difficult to test subject
would give some estimate ofthe subject's threshold
forthat particular stimulus. In addition, the latency
ofthe various waves ofthe BSER, particularly the
V wave, have been shown to exhibit recruitment
(35). The presence of this phenomenon can give a
good indication as to whether the pathology is of
cochlear origin or not. It would appear that this
technique holds considerable promise in evaluating
performance with hearing aids in difficult to test
subjects or subjects too young to respond in con-
ventional manner. It would seempossible topredict
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the gain of the amplification system by measuring
the latency ofthe V wave with and without ampli-
fication.
Another important aspect of the BSER is the
neural transmission time. This is a measure of the
latency between the I wave (i.e., primary auditory
nerve) and the otherwaves, givinga measure ofthe
travel time in the auditory brain stem system. This
measure has proved valuable in assessingthe site of
pathologies in the brain stem, such as acoustic
tumors, multiple sclerosis and brain stem vascular
and neoplastic lesions. In very young children, this
transmission time is also delayed, probably due to
incomplete maturation or myelination ofthe central
auditory pathways. This latency reaches normal
adult values, however, around one year of age.
Increased neural transmission time in older chil-
dren or adults with normal latencies for the I wave
may be an indication of lack of maturation, demye-
linating pathologies or the presence of space occu-
pying lesions, etc.
Another potentially important addition to the
auditory test battery for clinical assessment is the
use of high frequency audiometry. This measure-
ment of auditory function in the frequencies from
8000 Hz to 20,000 Hz has potential significance to
both clinical and research testing. Changes in high
frequency auditory thresholds have been described
as an early indication of ototoxic effects of certain
drugs and noise exposure (36-38). This procedure
has been used by several investigators; however, it
is not yet completely accepted as a clinical measure
because of difficulties in instrumentation (39-41).
This procedure, with adequate and stable instru-
mentation, could serve as a valuable function in
detecting early auditory dysfunction.
Clinical Assessment
As previously stated, clinical assessment ofaudi-
tory dysfunction usually includes a progressive bat-
tery oftests designed to indicate site-of-lesion. The
first order ofpriority is to determine the amount of
auditory dysfunction, if any, and the extent ofthis
dysfunction. This is normally accomplished with
puretonethresholdsforvariousfrequencies, speech
reception thresholds, and speech discrimination
scores. Assuming an auditory dysfunction is pres-
ent, the second order of priority is to determine if
this dysfunction is conductive, sensorineural, mixed
or central. A mixed-type hearing loss has compo-
nents of both conductive and sensorineural origin,
since these types ofhearing losses are not mutually
exclusive. This is normally accomplished with pure
tone bone conduction thresholds and the impedance
test battery. For a conductive hearingimpairment,
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normal or near normal in the presence of abnormal
pure tone air conduction thresholds. Speech recep-
tion thresholds should agree within + 10 dB of
average air conduction thresholds at 500, 1000 and
2000 Hz, and speech discrimination should be nor-
mal (90-100%). The impedance test battery should
show abnormal static compliance (either resistive
or compliant, depending on the nature ofthe hear-
ing loss), tympanometry should be abnormal (show-
ing a very compliant system, a very resistive sys-
tem, negative pressure or the presence of middle
ear effusions, depending on the site and type of
dysfunction), acoustic reflex should be absent (de-
pending on extent of conductive hearing loss), and
acoustic reflex decay will obviously not be mea-
sured if the reflex is absent. Reports in the litera-
ture have indicated that a very mild conductive
hearing loss will cause the absence of the acoustic
reflex in the affected ear (42). At this point, a
specific treatment protocol is indicated since the
majorityofconductivehearinglossescanbemedically
or surgically treated. Also, there is no concrete
evidence ofconductive hearinglossesresultingfrom
ototoxicity.
Should auditory tests indicate a sensorineural
hearing loss, the third order of priority is to delin-
eate between cochlear and retrocochlear involve-
ment. In the case of sensorineural hearing loss,
pure tone air conduction thresholds should be abnor-
mal, although they may vary from normal to total
deafness in retrocochlear lesions. Pure tone bone
conduction thresholds should agree reasonably well
with air conduction, indicating no involvement of
the external ormiddle ear. Speech reception thresh-
old should agree with average pure tone thresholds
and speech discrimination will usually be abnormal.
Inthe case ofcochlearinvolvement, speech discrim-
ination will usually vary between 50 and 90%, while
it is not unusual of retrocochlear involvement to
show speech discrimination scores much lower than
50%. The impedance test battery will usually show
specific types of patterns for cochlear and retro-
cochlear involvements. In both cases, static compli-
ance and tympanometry should be normal since
there is presumably no middle ear involvement.
Cochlearinvolvement, usually accompanied by loud-
ness recruitment, will normally show the presence
of an acoustic reflex if the hearing loss does not
exceed 75 to 85 dB. One indication of cochlear
involvement is the presence of acoustic reflexes at
abnormally low levels (42). If the reflex is present
in cochlear hearing loss, it will normally show no
significant decay. Retrocochlearlesions, onthe other
hand, will frequently present with an absence of
reflex, even in the presence of sufficient hearing to
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elicit this reflex. If the reflex is present in retro-
cochlear lesions, it usually decays abnormally.
The use of the classic diagnostic test battery is
also helpful in distinguishing between cochlear and
retrocochlear lesions. Usually the tests which indi-
cate an abnormal sensitivity to changes in loudness
(ABLB, SISI, and to some extent the Bekesy) will
showabnormalresultsincochlearlesions. TheABLB
will normally show the presence ofloudness recruit-
ment in the affected ear and the SISI will show a
highpercentageofsmallintensityincrementsdetected
(greaterthan60%). Inclassicalretrocochlearlesions,
these tests are usually normal, since abnormal sen-
sitivitytoloudnesschangesisassociatedwithcochlear
pathology. Tests which show abnormal adaptation,
such as the tone decay and to some extent the
Bekesy, will show no abnormal tone decay (less
than 25 dB) and a Type II Bekesy tracing. Retro-
cochlear lesions will normally indicate abnormal
fatigue or adaptation on the tone decay (greater
than 25 dB) and show Type III or Type IV Bekesy
tracings. The performance versus intensity func-
tion for speech discrimination (PI-PB) also shows
unique results forcochlearandretrocochlearlesions.
For cochlear lesions, this function will normally
reach a maximum discrimination and plateau or
showaveryslight decline. Forretrocochlearlesions,
however, this function will usually reach a maxi-
mum, although at a low discrimination level, and
show a severe decline or roll-over as intensity is
increased.
The brain stem evoked response has become one
ofthe most reliable tests in differentiating cochlear
and retrocochlear lesions. In conductive hearing
losses, the results are often quite variable, since it
may be difficult to present stimuli at sufficient
levelstoelicitadequateresponses. Incochlearlesions,
especially those exhibiting loudness recruitment,
BSER results are usually normal and may even
show a decreased latency when compared to the
level of stimulation. In retrocochlear lesions, the
BSERusuallyindicatesabnormallatencymeasures,
especially for waves III, IV and V. This test is
obviously useful in indicating other types oflesions
in the brain stem which might alter amplitude of
response or latency ofresponse. These may include
space occupying lesions and demyelinating lesions.
Table 1 shows the relationship between various
auditory tests used in clinical assessment and their
expected results in conductive, cochlear, and retro-
cochlear pathologies.
As indicated earlier, the majority of ototoxic
substances or agents have their direct effect on
various parts ofthe cochlea, with the noted excep-
tions. While clinical assessment cannot differenti-
atebetween variouspathologies oretiologies affecting
73Table 1. Hearing tests used in clinical assessment and expected results for conductive, cochlear and retrocochlear lesions.
Type of hearing loss
Conductive Cochlear Retrocochlear
Pure tone thresholds
Air conduction Abnormal Abnormal Variable
Bone conduction Normal Abnormal Variable
Speech reception threshold Abnormal Abnormal Variable
Speech discrimination Normal Abnormal Abnormal
Impedance battery
Static compliance Abnormal Normal Normal
Tympanometry Abnormal Normal Normal
Reflex threshold Absent (?) Abnormal Absent/Decay
Reflex decay N/A Normal/Absent Absent/Abnormal
Diagnostic battery
ABLB Normal Abnormal Normal
SISI Normal Abnormal Normal
Tone decay Normal Normal Abnormal
Bekesy Type I Type II Type III or IV
PI-PB No rollover Plateau Rollover
Brain stem evoked response Variable Normal/Variable Abnormal
the cochlea, results should indicate cochlear pathol-
ogyinthepresence ofototoxicsubstancesoragents.
The shape of the audiometric function frequently
can give an indication oftoxic damage to the inner
ear. Noise exposure, for example, usually has a
characteristic audiogram with the greatest loss at
3000, 4000 or 6000 Hz, while ototoxicity from drugs
or chemicals shows a progressive hearing loss as a
function offrequency, frequently severe in nature.
This hearingloss is usually accompanied by tinnitus
and occasionally by vertigo.
In clinical assessment of auditory dysfunction,
including that caused by ototoxicity, several points
should be made. In this section, descriptions such
asfrequently, usually andnormally areusedrepeat-
edly. This has not resulted from lack ofvocabulary,
but because of the variability in auditory tests.
Review of the pertinent literature indicates that
any single auditory test, taken alone, shows the
classic result in 60-90% of cases (6, 43-45). This
means that a relatively high percentage ofsubjects
(10-40%) may show retrocochlear signs on some
tests with cochlear lesions, or, cochlear signs in the
presence of retrocochlear lesions. In addition, the
nature of the lesion itself may cause damage in
more than one anatomical area. An acoustic tumor,
for example, which should indicate a retrocochlear
lesion, may also compromise the blood supplytothe
cochlea, causing cochlear damage. In this case, the
test results would be quite variable and show indi-
cations on various tests ofboth cochlear and retro-
cochlear lesions. The first point, therefore, is that
the entire test battery should be considered in the
assessment with less weight to the results of a
single test. The percentage of false positive and
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false negative results drops significantly when
expected results are found on two, three or four of
the tests in the battery. The second point is that
test results should be interpreted in conjunction
with a detailed case history. While an auditory test
battery may give an indication as to the site ofthe
lesion, the case history and other pertinent data
may shed light on the possible etiology.
The third major point in clinical assessment of
auditory dysfunction, particularly in the case of
ototoxicity, is the development ofadequate testing
protocols. Toxic effects on the human auditory sys-
tem are quite variable and the presence and extent
of damage depends on many parameters. Toxic
effects may occur immediately, as in the case of
many diuretics, occur within days, with various
drugs and chemicals, or occur over years, in the
case ofheavy metal toxicity and noise exposure. In
addition, decrease in auditory function may con-
tinue for months after the toxic substance has been
removed. Therefore, hearing assessment to detect
changes in auditory sensitivity should be on a regu-
lar basis, depending on the substance or agent
involved. In the case ofaminoglycosides, diuretics,
certain other antibiotics, and antineoplastics, test-
ing should probably occur on a weekly basis while
the subject is on the drug and monthly, up to six
months, after cessation of the drug. In the case of
analgesics and antipyretics, monthly to quarterly
testing is probably adequate. Exposure to noise or
heavy metal toxicity may require annual testing,
althoughtestingforheavymetaltoxicitymaydepend
on the blood levels of the heavy metal. It is also
obvious that pre-exposure assessment would be
ideal, to separate changes in auditory functionattrib-
Environmental Health Perspectivesuted to the ototoxic agent from pre-existing audi-
tory dysfunction and to serve as a baseline for
comparison of changes in auditory function. How-
ever, in many cases of life-threatening illness or
infection, documented decreases in auditory func-
tion resulting from the therapy may be purely
academic.
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